Gossamer Bio, Inc. (GOSS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Gossamer Bio, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.16x | -3.62x | -1.14x | -0.80x | -3.62x | -2.72x |
| P/B Ratio | -5.77x | 6.94x | 3.28x | 15.20x | 6.97x | 2.07x |
| P/S Ratio | 14.62x | 1.78x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 97.9% | 100.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | -336.8% | -52.2% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | -351.5% | -49.3% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | -334.7% | -34.8% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 2.64x | 6.88x | 5.94x | 5.32x | 8.32x | 13.51x |
| Quick Ratio | 2.64x | 6.88x | 5.94x | 5.32x | 8.32x | 13.51x |
| Leverage | ||||||
| Debt/Equity | -1.65x | 6.88x | 3.38x | 18.69x | 1.53x | 0.57x |
YoY = year-over-year change. Source: FMP..